Showing 11,521 - 11,540 results of 23,283 for search '(( 2 step decrease ) OR ( 100 ((((we decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.08s Refine Results
  1. 11521

    Data_Sheet_1_Differential Inhibition of Platelet Reactivity by Dual Therapy With Aspirin and Low-Dose Rivaroxaban in Peripheral Arterial Disease: A Pilot Study.pdf by Kerstin Jurk (755323)

    Published 2022
    “…ASA plus rivaroxaban treatment resulted in a significantly decreased thrombin peak in PRP for two triggers, namely, low concentration of tissue factor (TF) and thrombin, compared to ASA monotherapy. …”
  2. 11522
  3. 11523

    Data_Sheet_1_Low-Volume Polyethylene Glycol Improved Patient Attendance in Bowel Preparation Before Colonoscopy: A Meta-Analysis With Trial Sequential Analysis.PDF by Li-Juan Yi (6667178)

    Published 2019
    “…Meta-analysis based on PP analysis indicated that compared to standard volume PEG regime, low volume regime improved patient compliance RR = 1.01; 95% CIs = 1.00, 1.03; P = 0.143 (≥75% intake); RR = 1.07; 95% CIs = 1.00, 1.14; P = 0.046 (100% intake), the willingness to repeat the same regime (RR = 1.30; 95% CIs = 1.07, 157; P = 0.007), and patient acceptability (RR = 1.18; 95% CIs = 1.07, 1.29; P = 0.001), and decreased the overall adverse events (RR = 0.86; 95% CIs = 0.77, 0.96; P = 0.009). …”
  4. 11524

    Data_Sheet_2_Low-Volume Polyethylene Glycol Improved Patient Attendance in Bowel Preparation Before Colonoscopy: A Meta-Analysis With Trial Sequential Analysis.PDF by Li-Juan Yi (6667178)

    Published 2019
    “…Meta-analysis based on PP analysis indicated that compared to standard volume PEG regime, low volume regime improved patient compliance RR = 1.01; 95% CIs = 1.00, 1.03; P = 0.143 (≥75% intake); RR = 1.07; 95% CIs = 1.00, 1.14; P = 0.046 (100% intake), the willingness to repeat the same regime (RR = 1.30; 95% CIs = 1.07, 157; P = 0.007), and patient acceptability (RR = 1.18; 95% CIs = 1.07, 1.29; P = 0.001), and decreased the overall adverse events (RR = 0.86; 95% CIs = 0.77, 0.96; P = 0.009). …”
  5. 11525

    Result of using Q-learning with a similar training configuration to that used for our model, i.e., maximum 100000 steps for each episode and sparse reward. by Tianqi Wei (16446246)

    Published 2024
    “…<p>Blue line: Episode reward. Yellow line: 100 episode average reward. The Left shows the reward per episode and the right reward per step. …”
  6. 11526

    Data Sheet 1_Analysis of serum amino acids and tryptophan metabolites to predict hepatic encephalopathy in portal hypertension patients receiving a transjugular intrahepatic portal... by Li Bao (323211)

    Published 2025
    “…Introduction<p>The incidence of hepatic encephalopathy (HE) after transjugular intrahepatic portal shunt (TIPS) is over 30%, how to decrease the occurrence rate of HE is one of the most challenging issues after TIPS surgery. …”
  7. 11527

    Fig 5 - by Kevin Tsai (197484)

    Published 2024
    “…Case 2 is of the identical setup to Case 1 except that the scaling power <i>n</i> completes the reduction in 1×10<sup>4</sup> simulation time steps. …”
  8. 11528

    Data_Sheet_1_Chemodiversity of Soil Dissolved Organic Matter and Its Association With Soil Microbial Communities Along a Chronosequence of Chinese Fir Monoculture Plantations.docx by Ying Li (38224)

    Published 2022
    “…This study characterized the chemodiversity of soil DOM, assessed the variation of the soil microbial community composition, and identified specific linkages between DOM molecules and microbial community composition in soil samples from a 100-year chronosequence of Chinese fir monoculture plantations. …”
  9. 11529

    Data_Sheet_1_Chemodiversity of Soil Dissolved Organic Matter and Its Association With Soil Microbial Communities Along a Chronosequence of Chinese Fir Monoculture Plantations.docx by Ying Li (38224)

    Published 2021
    “…This study characterized the chemodiversity of soil DOM, assessed the variation of the soil microbial community composition, and identified specific linkages between DOM molecules and microbial community composition in soil samples from a 100-year chronosequence of Chinese fir monoculture plantations. …”
  10. 11530

    Data_Sheet_2_Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Met... by Chen Chen (6544)

    Published 2021
    “…</p><p>Results: Six clinical trials with a total of 1,208 participants were included. We found that combined 5-FU and LMWH infusion did not improve the primary success of vitrectomy at 6 months (RR = 1.00, 95% CI = 0.95, 1.07, P = 0.89, I<sup>2</sup> = 50%). …”
  11. 11531

    Data_Sheet_1_Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Met... by Chen Chen (6544)

    Published 2021
    “…</p><p>Results: Six clinical trials with a total of 1,208 participants were included. We found that combined 5-FU and LMWH infusion did not improve the primary success of vitrectomy at 6 months (RR = 1.00, 95% CI = 0.95, 1.07, P = 0.89, I<sup>2</sup> = 50%). …”
  12. 11532

    Data_Sheet_4_Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Met... by Chen Chen (6544)

    Published 2021
    “…</p><p>Results: Six clinical trials with a total of 1,208 participants were included. We found that combined 5-FU and LMWH infusion did not improve the primary success of vitrectomy at 6 months (RR = 1.00, 95% CI = 0.95, 1.07, P = 0.89, I<sup>2</sup> = 50%). …”
  13. 11533

    Data_Sheet_3_Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Met... by Chen Chen (6544)

    Published 2021
    “…</p><p>Results: Six clinical trials with a total of 1,208 participants were included. We found that combined 5-FU and LMWH infusion did not improve the primary success of vitrectomy at 6 months (RR = 1.00, 95% CI = 0.95, 1.07, P = 0.89, I<sup>2</sup> = 50%). …”
  14. 11534

    DataSheet3_“Tranq-dope” overdose and mortality: lethality induced by fentanyl and xylazine.DOCX by Mark A. Smith (21079)

    Published 2023
    “…Notably, a nonlethal dose of xylazine (100 mg/kg) produced an approximately 100-fold decrease in the estimated LD<sub>50</sub> for fentanyl. …”
  15. 11535

    DataSheet2_“Tranq-dope” overdose and mortality: lethality induced by fentanyl and xylazine.DOCX by Mark A. Smith (21079)

    Published 2023
    “…Notably, a nonlethal dose of xylazine (100 mg/kg) produced an approximately 100-fold decrease in the estimated LD<sub>50</sub> for fentanyl. …”
  16. 11536

    DataSheet1_“Tranq-dope” overdose and mortality: lethality induced by fentanyl and xylazine.DOCX by Mark A. Smith (21079)

    Published 2023
    “…Notably, a nonlethal dose of xylazine (100 mg/kg) produced an approximately 100-fold decrease in the estimated LD<sub>50</sub> for fentanyl. …”
  17. 11537

    Luciferase activity and S/MAR MCs are slowly lost over time in labeled cell populations. by John A. Ronald (451321)

    Published 2013
    “…All clones showed a trend (p = 0.18) towards decreased normalized luciferase expression over long periods of time in culture. …”
  18. 11538

    Plot of stable nodule <i>k</i> (growth rate) estimates for all non-calcified nodules as a function of scan interval, <i>ΔT</i>. by Gary T. Smith (797158)

    Published 2015
    “…There were no false positive results for a scan interval greater than 100 days. Note the decreasing error in <i>k</i> with increasing scan interval time. …”
  19. 11539

    Table_1_Kinesiophobia Severity Categories and Clinically Meaningful Symptom Change in Persons With Achilles Tendinopathy in a Cross-Sectional Study: Implications for Assessment and... by Ruth L. Chimenti (10939173)

    Published 2021
    “…Half of respondents considered a 5-min (35% of sample) or 10-min (16%) decrease in morning stiffness as clinically meaningful.…”
  20. 11540